(Reuters) – Moderna Inc mentioned on Tuesday it had acquired a report from California’s well being division that a number of individuals at a middle in San Diego had been handled for doable allergic reactions to its COVID-19 vaccine from a specific batch.
The corporate’s feedback come after California’s prime epidemiologist on Sunday issued an announcement recommending suppliers pause vaccination from lot no. 41L20A because of doable allergic reactions which might be below investigation.
“The next-than-usual variety of doable allergic reactions had been reported with a selected lot of Moderna vaccine administered at one group vaccination clinic. Fewer than 10 people required medical consideration over the span of 24 hours,” the epidemiologist mentioned in an announcement here.
The vaccine maker mentioned it was unaware of comparable instances of adversarial occasions from different vaccination facilities which can have administered vaccines from the identical lot or from different numerous its vaccine.
A complete of 307,300 doses from the lot stay in storage, Moderna mentioned, of the full 1,272,200 doses that had been produced within the batch.
Moderna mentioned it was working carefully with U.S. well being regulators to know the instances and whether or not pausing the usage of the lot was warranted.
Almost one million doses from the lot have already been distributed to about 1,700 vaccination websites in 37 states, Moderna mentioned. (bit.ly/39MPtlF)
Reporting by Manojna Maddipatla in Bengaluru; Enhancing by Vinay Dwivedi and Shinjini Ganguli